dapsone has been researched along with DRESS Syndrome in 18 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dapsone hypersensitivity syndrome (DHS) is restricted to HLA-B∗13:01." | 8.31 | TAP2 Drives HLA-B∗13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity. ( Liu, H; Liu, T; Mi, Z; Sun, L; Sun, Y; Wang, Z; Xue, X; You, J; Yu, G; Yue, Z; Zhang, F; Zhao, Q, 2023) |
| " Although rare, DRESS syndrome triggered by specific agents has been associated with specific genetic polymorphisms more prevalent in different ethnic groups, including an association between dapsone-induced DRESS and Human Leukocyte Antigen (HLA)-B:13*01, a single nucleotide polymorphism more prevalent in those of Asian descent." | 7.96 | Dapsone-induced DRESS after infliximab-induced vasculitis: a case of cerebral infarction in the context of multiple drug reactions. ( Clark, PA; Gray, JT; Peterson, PG; Roth, M, 2020) |
| "Dapsone hypersensitivity syndrome (DHS) is the most serious adverse reaction associated with dapsone administration and one of the major causes of death in patients with leprosy, whose standard treatment includes multidrug therapy (MDT) with dapsone, rifampicin, and clofazimine." | 7.91 | Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy. ( Bao, F; Cao, J; Cao, Q; Chai, Z; Chen, S; Cheng, X; Chu, T; Duan, Q; Fu, F; Fu, X; Irwanto, A; Ke, W; Krismawati, H; Kuang, Y; Lang, X; Li, J; Li, L; Li, M; Li, W; Lin, Z; Liu, D; Liu, H; Liu, J; Liu, Q; Mi, Z; Ning, Y; Pan, Q; Shang, X; Shen, J; Shen, Y; Sun, L; Sun, Y; Wang, C; Wang, H; Wang, L; Wang, X; Wang, Y; Wang, Z; Wu, W; Xiao, B; Xiao, P; Xiong, F; Xiong, J; Xiong, L; Xiong, M; Xu, Y; Yan, L; Yang, B; Yang, J; You, J; Yu, G; Yu, W; Yue, Z; Zhan, X; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhao, Q; Zhao, W; Zheng, H, 2019) |
| "A 73-year-old man was admitted in respiratory failure that had subacutely progressed after five weeks of dapsone treatment for a skin rash." | 5.42 | Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid. ( Fukushima, K; Hayama, Y; Higashiguchi, M; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kinehara, Y; Kumanogoh, A; Minami, T; Miyake, K; Morimura, O; Nagatomo, I; Takeda, Y; Takeuchi, Y, 2015) |
| "Dapsone hypersensitivity syndrome (DHS) is restricted to HLA-B∗13:01." | 4.31 | TAP2 Drives HLA-B∗13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity. ( Liu, H; Liu, T; Mi, Z; Sun, L; Sun, Y; Wang, Z; Xue, X; You, J; Yu, G; Yue, Z; Zhang, F; Zhao, Q, 2023) |
| " Although rare, DRESS syndrome triggered by specific agents has been associated with specific genetic polymorphisms more prevalent in different ethnic groups, including an association between dapsone-induced DRESS and Human Leukocyte Antigen (HLA)-B:13*01, a single nucleotide polymorphism more prevalent in those of Asian descent." | 3.96 | Dapsone-induced DRESS after infliximab-induced vasculitis: a case of cerebral infarction in the context of multiple drug reactions. ( Clark, PA; Gray, JT; Peterson, PG; Roth, M, 2020) |
| "Dapsone hypersensitivity syndrome (DHS) is the most serious adverse reaction associated with dapsone administration and one of the major causes of death in patients with leprosy, whose standard treatment includes multidrug therapy (MDT) with dapsone, rifampicin, and clofazimine." | 3.91 | Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy. ( Bao, F; Cao, J; Cao, Q; Chai, Z; Chen, S; Cheng, X; Chu, T; Duan, Q; Fu, F; Fu, X; Irwanto, A; Ke, W; Krismawati, H; Kuang, Y; Lang, X; Li, J; Li, L; Li, M; Li, W; Lin, Z; Liu, D; Liu, H; Liu, J; Liu, Q; Mi, Z; Ning, Y; Pan, Q; Shang, X; Shen, J; Shen, Y; Sun, L; Sun, Y; Wang, C; Wang, H; Wang, L; Wang, X; Wang, Y; Wang, Z; Wu, W; Xiao, B; Xiao, P; Xiong, F; Xiong, J; Xiong, L; Xiong, M; Xu, Y; Yan, L; Yang, B; Yang, J; You, J; Yu, G; Yu, W; Yue, Z; Zhan, X; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhao, Q; Zhao, W; Zheng, H, 2019) |
| "Dapsone (4,4'-diaminodiphenylsulfone) has been widely used for the treatment of infections such as leprosy." | 3.85 | A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome. ( Gouda, H; Hashizume, H; Kusakabe, Y; Mushiroda, T; Ozeki, T; Sueki, H; Tashiro, Y; Utsunomiya-Tate, N; Watanabe, H; Watanabe, Y; Yamamoto, T, 2017) |
| "Dapsone is an extensively Used drug for the treatment of leprosy as well as'some other clinical problems worldwide: Its use has been predicted to increase further, especially in non leprosy conditions." | 3.83 | Dapsone: An Update. ( Aruna, B; Kallappa, H; Karjigi, S; Kusuma, MR; Murthy, SC; Reddy, YN, 2016) |
| "Eosinophilia was present in 18 (90%) patients with mean (±SD) value of 1976 ± 840 cells/μl." | 1.62 | Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study. ( Neema, S; Radhakrishnan, S; Sandhu, S; Sengupta, P; Vashisht, D; Venugopal, R, 2021) |
| "A 73-year-old man was admitted in respiratory failure that had subacutely progressed after five weeks of dapsone treatment for a skin rash." | 1.42 | Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid. ( Fukushima, K; Hayama, Y; Higashiguchi, M; Hirata, H; Inoue, K; Kida, H; Kijima, T; Kinehara, Y; Kumanogoh, A; Minami, T; Miyake, K; Morimura, O; Nagatomo, I; Takeda, Y; Takeuchi, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, L | 4 |
| Wang, Z | 3 |
| Liu, T | 1 |
| Zhao, Q | 4 |
| Yu, G | 3 |
| Sun, Y | 3 |
| Xue, X | 1 |
| You, J | 3 |
| Yue, Z | 2 |
| Mi, Z | 3 |
| Liu, H | 4 |
| Zhang, F | 4 |
| Zhang, H | 2 |
| Huai, P | 1 |
| Pang, Z | 1 |
| Park, HJ | 1 |
| Park, JW | 1 |
| Kim, SH | 1 |
| Choi, SY | 1 |
| Kim, HK | 1 |
| Jung, CG | 1 |
| Yang, MS | 1 |
| Kang, DY | 1 |
| Cho, MK | 1 |
| Kwon, HS | 1 |
| Kang, HR | 1 |
| Lee, YW | 1 |
| Sandhu, S | 1 |
| Neema, S | 1 |
| Vashisht, D | 1 |
| Venugopal, R | 1 |
| Sengupta, P | 1 |
| Radhakrishnan, S | 1 |
| Roth, M | 1 |
| Gray, JT | 1 |
| Peterson, PG | 1 |
| Clark, PA | 1 |
| Almutairi, M | 1 |
| Tailor, A | 1 |
| Lister, A | 1 |
| Harper, N | 1 |
| Line, J | 1 |
| Meng, X | 1 |
| Pratoomwun, J | 1 |
| Jaruthamsophon, K | 1 |
| Sukasem, C | 1 |
| Ogese, MO | 1 |
| MacEwan, DJ | 1 |
| Pirmohamed, M | 1 |
| Liu, J | 3 |
| Ostrov, DA | 1 |
| Naisbitt, DJ | 1 |
| Watanabe, H | 1 |
| Watanabe, Y | 1 |
| Tashiro, Y | 1 |
| Mushiroda, T | 1 |
| Ozeki, T | 1 |
| Hashizume, H | 1 |
| Sueki, H | 1 |
| Yamamoto, T | 1 |
| Utsunomiya-Tate, N | 1 |
| Gouda, H | 1 |
| Kusakabe, Y | 1 |
| de Nardo Vanzela, T | 1 |
| Bernardes Filho, F | 1 |
| Wambier, CG | 1 |
| Faria, FM | 1 |
| Foss, NT | 1 |
| Frade, MAC | 1 |
| Chen, WT | 1 |
| Wang, CW | 1 |
| Lu, CW | 1 |
| Chen, CB | 1 |
| Lee, HE | 1 |
| Hung, SI | 1 |
| Choon, SE | 1 |
| Yang, CH | 1 |
| Liu, MT | 1 |
| Chen, TJ | 1 |
| Fan, WL | 1 |
| Su, SC | 1 |
| Lin, YY | 1 |
| Chang, YC | 1 |
| Chung, WH | 1 |
| Cai, F | 1 |
| Lucas, M | 1 |
| Yun, J | 1 |
| Tangamornsuksan, W | 1 |
| Lohitnavy, M | 1 |
| Karjigi, S | 1 |
| Murthy, SC | 1 |
| Kallappa, H | 1 |
| Kusuma, MR | 1 |
| Aruna, B | 1 |
| Reddy, YN | 1 |
| Ordieres Ortega, L | 1 |
| Temiño Frade, C | 1 |
| Demelo-Rodríguez, P | 1 |
| Bao, F | 1 |
| Wang, C | 1 |
| Li, J | 3 |
| Li, L | 1 |
| Zhao, W | 1 |
| Yu, W | 1 |
| Cao, J | 1 |
| Xiong, F | 1 |
| Wang, Y | 2 |
| Chai, Z | 1 |
| Cheng, X | 1 |
| Zhang, Y | 1 |
| Fu, F | 1 |
| Lang, X | 1 |
| Wang, X | 1 |
| Irwanto, A | 1 |
| Krismawati, H | 1 |
| Fu, X | 1 |
| Pan, Q | 1 |
| Chu, T | 1 |
| Liu, D | 1 |
| Chen, S | 1 |
| Shen, J | 1 |
| Yan, L | 2 |
| Zhang, G | 1 |
| Xiong, L | 1 |
| Yang, J | 1 |
| Ke, W | 1 |
| Li, M | 2 |
| Ning, Y | 1 |
| Xiong, J | 1 |
| Xiong, M | 1 |
| Yang, B | 1 |
| Duan, Q | 1 |
| Wang, H | 1 |
| Li, W | 2 |
| Kuang, Y | 1 |
| Wang, L | 1 |
| Cao, Q | 1 |
| Xiao, P | 1 |
| Xiao, B | 1 |
| Zhang, L | 1 |
| Lin, Z | 1 |
| Shen, Y | 1 |
| Wu, W | 1 |
| Zheng, H | 1 |
| Zhan, X | 1 |
| Shang, X | 1 |
| Xu, Y | 1 |
| Liu, Q | 1 |
| Markova, A | 1 |
| Duquesnoy, R | 1 |
| Levis, W | 1 |
| Kinehara, Y | 1 |
| Kijima, T | 1 |
| Inoue, K | 1 |
| Hirata, H | 1 |
| Takeuchi, Y | 1 |
| Fukushima, K | 1 |
| Hayama, Y | 1 |
| Higashiguchi, M | 1 |
| Morimura, O | 1 |
| Miyake, K | 1 |
| Minami, T | 1 |
| Nagatomo, I | 1 |
| Takeda, Y | 1 |
| Kida, H | 1 |
| Kumanogoh, A | 1 |
| Schulkes, KJ | 1 |
| Tervaert, JW | 1 |
| Rijken, F | 1 |
| Haas, LE | 1 |
| Gopinath, H | 1 |
| Nayak, K | 1 |
| Kumar, P | 1 |
| Chakraborti, S | 1 |
2 reviews available for dapsone and DRESS Syndrome
| Article | Year |
|---|---|
The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses.
Topics: Adult; Aged; Asian People; Child; Dapsone; Drug Hypersensitivity Syndrome; Female; Genotype; HLA-B13 | 2020 |
Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
Topics: Anti-Infective Agents; Dapsone; Drug Eruptions; Drug Hypersensitivity Syndrome; Genotype; HLA-B13 An | 2018 |
16 other studies available for dapsone and DRESS Syndrome
| Article | Year |
|---|---|
TAP2 Drives HLA-B∗13:01‒Linked Dapsone Hypersensitivity Syndrome Tolerance and Reactivity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 3; Dapsone; Drug Hypersensitivity Syndrome; Ep | 2023 |
Dynamic cytokine profiles combined with enzyme-linked immunospot assay are useful for immunologically confirming the dapsone hypersensitivity syndrome.
Topics: Adult; Biomarkers; Cytokines; Dapsone; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Enzy | 2021 |
Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Topics: Adult; Dapsone; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Methylprednisolone; Middle Age | 2021 |
Dapsone-induced DRESS after infliximab-induced vasculitis: a case of cerebral infarction in the context of multiple drug reactions.
Topics: Adult; Brain; Cerebral Infarction; Crohn Disease; Dapsone; Drug Hypersensitivity Syndrome; Female; G | 2020 |
HLA Class-II‒Restricted CD8
Topics: Adult; Alleles; CD8-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Dapsone; Drug Hypersensitivit | 2021 |
A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome.
Topics: Computational Biology; Dapsone; Drug Hypersensitivity Syndrome; HLA-B Antigens; Humans; Leprostatic | 2017 |
Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome: Case Report.
Topics: Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Th17 | 2018 |
The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.
Topics: Adult; Aged, 80 and over; Alleles; Antigens, Differentiation, T-Lymphocyte; Coculture Techniques; Da | 2018 |
Dapsone-induced drug reaction with eosinophilia and systemic symptoms associated with HLA-B*13:01.
Topics: Anti-Infective Agents; Dapsone; Drug Hypersensitivity Syndrome; Eosinophilia; HLA-B Antigens; Humans | 2018 |
Dapsone: An Update.
Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy; Methe | 2016 |
Late onset dapsone hypersensitivity syndrome.
Topics: Aged, 80 and over; Anemia; Dapsone; Drug Hypersensitivity Syndrome; Erythema Multiforme; Erythrocyte | 2019 |
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Topics: Adult; Alleles; China; Clofazimine; Cohort Studies; Dapsone; Drug Hypersensitivity Syndrome; Drug Th | 2019 |
T-cell plasticity of dapsone and DRESS.
Topics: Adult; Dapsone; Drug Hypersensitivity Syndrome; Female; Humans; Leprostatic Agents; Leprosy, Leproma | 2014 |
Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid.
Topics: Acute Lung Injury; Aged; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Dapsone; Diagnosis, Di | 2015 |
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Topics: Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Dapsone; Diagnosis, Differential; Dru | 2015 |
Spared white islands in a drug rash: revisiting sparing phenomenon in Hansen's disease.
Topics: Adolescent; Dapsone; Drug Hypersensitivity Syndrome; Humans; Leprostatic Agents; Leprosy, Borderline | 2017 |